Oregon, Washington, Idaho Part Of Multi-State Pharmaceutical Settlement


  • Playlist
  • Download
  • Embed
    Embed <iframe src="http://www.npr.org/player/embed/165240538/165240556" width="100%" height="290" frameborder="0" scrolling="no">
  • Transcript

Oregon, Washington and Idaho are part of a $90 million, 38 state settlement announced Thursday with pharmaceutical giant GlaxoSmithKline. The lawsuit claims the drug company downplayed the cardiovascular risks of the diabetes drug Avandia , which has been linked to an increased risk of heart attacks.

It's the third major pharmaceutical settlement announced by Oregon Attorney General Ellen Rosenblum since she took office in June. Each case began under her predecessor, John Kroger.

But Justice Department spokesman, Jeff Manning, says the Attorney General will continue going after drug companies.

"When you're talking about a giant pharmaceutical company misrepresenting the safety aspects of a widely-marketed drug, that is right in the wheelhouse of the Department of Justice."

No Alternative Text

Oregon Attorney General Ellen Rosenblum has announced a third major pharmaceutical settlement since she took office. hide caption

itoggle caption

As one of the lead plaintiffs, Oregon gets a larger share of the settlement. Manning says the state has recovered more than $18 million from pharmaceutical companies in the past two years.

Copyright 2012 Northwest News Network



Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.